SCHEMBL13007336

SCHEMBL13007336

COc1cc(COc2cc3ccn(C)c(=O)c3cc2OC)cc(OC)c1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 1/20 0.52
MTNR1B P49286 1/20 0.52
TNF P01375 3/20 0.44
ALOX5 P09917 1/20 0.41
CTSL P07711 2/20 0.40
CTSB P07858 1/20 0.40
PSMB1 P20618 4/20 0.40
PSMB2 P49721 3/20 0.40
PSMB5 P28074 3/20 0.40
SRD5A1 P18405 1/20 0.39
SRD5A2 P31213 1/20 0.39
ABCB1 P08183 3/20 0.39
PTP4A3 O75365 1/20 0.39
PDE3B Q13370 1/20 0.38
PDE3A Q14432 1/20 0.38
PDE10A Q9Y233 1/20 0.38
ENPP2 Q13822 1/20 0.38
TDP1 Q9NUW8 1/20 0.37
CTSV O60911 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13007334 1.00 MTNR1A (0.52) MTNR1AMTNR1BTNFALOX5CTSL
SCHEMBL13007335 0.90 MTNR1A (0.66) MTNR1AMTNR1BCTSLCTSBABCB1
SCHEMBL13007337 0.90 MTNR1A (0.66) MTNR1AMTNR1BCTSLCTSBABCB1
SCHEMBL16328854 0.83 TNF (0.53) MTNR1AMTNR1BTNFPSMB1PSMB2
SCHEMBL14149433 0.81 TNF (0.48) MTNR1AMTNR1BTNFPSMB1PSMB2
SCHEMBL13007345 0.78 MTNR1B (0.81) MTNR1AMTNR1BABCB1ENPP2
SCHEMBL13007333 0.78 TNF (0.46) MTNR1AMTNR1BTNFPSMB1PSMB2
SCHEMBL14106255 0.72 TNF (0.47) MTNR1AMTNR1BTNFPSMB1PSMB2
SCHEMBL25219017 0.72 TNF (0.43) MTNR1AMTNR1BTNFPSMB1PSMB2
SCHEMBL23946136 0.72 TNF (0.46) MTNR1AMTNR1BTNFPSMB1PSMB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8389544-B2 Isoquinolone compounds as subtype-selective agonists for melatonin receptors MT1 and MT2 THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2013-03-05 US disclosed
US-8389544-B2 Isoquinolone compounds as subtype-selective agonists for melatonin receptors MT1 and MT2 THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2013-03-05 US disclosed
US-20100317691-A1 ISOQUINOLONE COMPOUNDS AS SUBTYPE-SELECTIVE AGONISTS FOR MELATONIN RECEPTORS MT1 AND MT2 THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2010-12-16 US disclosed
US-20100317691-A1 ISOQUINOLONE COMPOUNDS AS SUBTYPE-SELECTIVE AGONISTS FOR MELATONIN RECEPTORS MT1 AND MT2 THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2010-12-16 US disclosed
WO-2008092292-A1 ISOQUINOLONE COMPOUNDS AS SUBTYPE-SELECTIVE AGONISTS FOR MELATONIN RECEPTORS MT1 AND MT2 THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2008-08-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317691-A1 ISOQUINOLONE COMPOUNDS AS SUBTYPE-SELECTIVE AGONISTS FOR MELATONIN RECEPTORS MT1 AND MT2 MTNR1A, MTNR1B, MC2R MTNR1A 1/4885MTNR1B 2/4885TNF 3844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.